Next Article in Journal
Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
Next Article in Special Issue
Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis
Previous Article in Journal
Urine HPV in the Context of Genital and Cervical Cancer Screening—An Update of Current Literature
Previous Article in Special Issue
Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
Review

Targeting the Metabolic Adaptation of Metastatic Cancer

1
Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine of Universitat de Barcelona (IBUB), Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Spain
2
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28020 Madrid, Spain
3
Metabolomics Node at Spanish National Bioinformatics Institute (INB-ISCIII-ES-ELIXIR), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain
*
Author to whom correspondence should be addressed.
Academic Editors: Lingzhi Wang and Qiang Jeremy Wen
Cancers 2021, 13(7), 1641; https://doi.org/10.3390/cancers13071641
Received: 27 February 2021 / Revised: 16 March 2021 / Accepted: 19 March 2021 / Published: 1 April 2021
(This article belongs to the Special Issue Targeting Cancer Metastasis)
The search for new therapeutic opportunities to target cancer metastasis is crucial for the improvement of cancer treatment. One of the characteristics of tumoral and metastatic cells is the capacity to reorganize their metabolism, together with the ability to grow faster, migrate and form new tumours in distant sites. Therefore, the pharmaceutical inhibition of metabolic pathways represents a promising strategy to specifically target metastatic cells, especially in colorectal cancer metastasis.
Metabolic adaptation is emerging as an important hallmark of cancer and metastasis. In the last decade, increasing evidence has shown the importance of metabolic alterations underlying the metastatic process, especially in breast cancer metastasis but also in colorectal cancer metastasis. Being the main cause of cancer-related deaths, it is of great importance to developing new therapeutic strategies that specifically target metastatic cells. In this regard, targeting metabolic pathways of metastatic cells is one of the more promising windows for new therapies of metastatic colorectal cancer, where still there are no approved inhibitors against metabolic targets. In this study, we review the recent advances in the field of metabolic adaptation of cancer metastasis, focusing our attention on colorectal cancer. In addition, we also review the current status of metabolic inhibitors for cancer treatment. View Full-Text
Keywords: colon cancer; metabolism; metastasis colon cancer; metabolism; metastasis
Show Figures

Figure 1

MDPI and ACS Style

Tarragó-Celada, J.; Cascante, M. Targeting the Metabolic Adaptation of Metastatic Cancer. Cancers 2021, 13, 1641. https://doi.org/10.3390/cancers13071641

AMA Style

Tarragó-Celada J, Cascante M. Targeting the Metabolic Adaptation of Metastatic Cancer. Cancers. 2021; 13(7):1641. https://doi.org/10.3390/cancers13071641

Chicago/Turabian Style

Tarragó-Celada, Josep, and Marta Cascante. 2021. "Targeting the Metabolic Adaptation of Metastatic Cancer" Cancers 13, no. 7: 1641. https://doi.org/10.3390/cancers13071641

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop